Abstract Details

<< Back to Detailed Agenda

9/24/2018  |   3:00 PM - 4:30 PM   |  Catamount Room

Demystifying Newborn Screening

Newborn screening is one of the cited public health breakthroughs. Beginning in the 1960swith the screening for phenylketonuria (PKU), screening newborns for a variety of genetic, metabolic, or infectious diseases hasled to a significant reduction of death, disease, and disabilities in newborns. The panel of newborn disorders screened for varies bystateand decisions for adding or deleting tests involvemany complex social, ethical,and political issues. This presentation will provide a brief history of newborn screening, the process of how conditions are considered for the Recommended Universal Screening Panel (RUSP) and discuss some of the challenges faced with screening and follow-up

Presentation:
This presentation has not yet been uploaded.

Handouts:
No handouts have been uploaded.


Coleen Boyle (Primary Presenter), cab3@cdc.gov;
tba

      ASHA DISCLOSURE:

Financial - No relevant financial relationship exists.

Nonfinancial - No relevant nonfinancial relationship exists.


      AAA DISCLOSURE:

Financial - No relevant financial relationship exists.